Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial

Publication | Open Access

DOI Full Paper Access

197

Citations

References

2014

Year

Hervé Bonnefoi, Saskia Litière, Martine Piccart, Gaëtan MacGrogan, P. Fumoleau, Étienne Brain, Thierry Petit, Philippe Rouanet, Jacek Jassem, Cosmin Moldovan,

Annals of Oncology

Breast OncologyEortc 10994/BigMedicinePathologyPathological Complete ResponseBiostatisticsBreast CancerCancer TreatmentOncologyNeoadjuvant Chemotherapy